Robert A. Vukovich

Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA.

Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA.

HealthCare Ventures LLC (HealthCare Ventures) is a venture capital firm founded in 1985 by Harold R. Werner. The firm is headquartered in Cambridge, Massachusetts.

Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL.

Part of Takeda Pharmaceutical Co., Ltd., ProScript, Inc. is a company that develops anti-cancer treatments. The company is based in Cambridge, MA. The company was founded by Tom Maniatis. ProScript was acquired by LeukoSite, Inc., part of Takeda Pharmaceutical Co., Ltd. from December 22, 1999 on July 20, 1999 for $3.35 million.

Part of NPS Allelix Corp., Trophix Pharmaceuticals, Inc. develops pharmaceutical products. The company is based in South Plainfield, NJ. The company was founded by Jeffrey F. McKelvy. Trophix Pharmaceuticals was acquired by Allelix Biopharmaceuticals, Inc. on July 30, 1997 for $27 million.

Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation.

Nabors Industries, Inc. engages in the provision of innovative drilling rigs and equipment. It offers drilling technology, software and equipment, directional drilling and drilling services in oil and gas markets. The company was founded by Clair Nabors in 1952 and is headquartered in Houston, TX.

One Thousand & One Voices (1k1v) is a private equity firm founded in 2013 by Hendrik Jordaa. The firm is headquartered in Stellenbosch, South Africa with additional offices in Mauritius and United States.

TPG Europe LLP provides investment advisory services. The company was founded on August 9, 2004 and is headquartered in London, the United Kingdom.

Authentic Brands Group LLC engages in the development, acquisition and management consumer brands. Its business solutions include ABG direct, licencing, research and development and direct to retail. It acquires and manages consumer brands in the apparel, sporting goods, action sports and home, celebrity, entertainment and consumer electronics segments. The firm serves retailers, wholesalers, manufacturers and direct-to-consumer channels worldwide. The company was founded by James Salter in 2010 and is headquartered in New York, NY.

Opna Immuno-Oncology SA is a Swiss biotechnology company that focuses on researching and developing biotechnology products. The private company is based in Saint-Sulpice, Switzerland.

Authentic Brands Group, Inc. is a holding company that engages in the provision of brand licensing services. Its services include brand development, marketing, and entertainment. Its portfolio focuses in the Lifestyle and Entertainment pillars. The company was founded by James Salter in 2010 and is headquartered in New York, NY.

Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA.

Pequot Capital Corp. provides investment advisory services.

CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA.

National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC.

Rivus Pharmaceuticals, Inc. is a company dedicated to improving metabolic health by advancing a new class of medicines called controlled metabolic accelerators (CMAs). The company is based in Charlottesville, VA. Jayson Donald Alexander Dallas has been the CEO of the company since 2021. The company is a leader in mitochondrial biology and is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity. Rivus' lead CMA is the investigational small molecule HU6 in development to treat obesity and associated metabolic diseases, including heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH), and type 2 diabetes.

Dascena, Inc. develops machine learning algorithms to enable early disease intervention. The company was founded by Ritankar Das and is headquartered in Oakland, CA.

Lemo USA, Inc. designs and manufactures custom connectors. It offers low voltage connectors, plastic and miniature connectors, high pressure and high voltage connectors, media converter, and cable assemblies. The company is headquartered in Rohnert Park, CA.

Right To Play International is an organization that empowers children through play. Right To Play International is based in Toronto, CA, and has subsidiaries in Netherlands, Switzerland, and United Kingdom. The organization provides children with the necessary tools and skills to create opportunities where there are none. Through various forms of play, children discover their own power, learn to believe in themselves, and realize possibilities. The organization aims to help vulnerable children who face challenges such as violence, child labor, early marriage, illiteracy, and inequality. The Canadian company was founded by Johann Olav Koss, and Susan J. McIsaac has been the CEO of the company since 2019.

Securities Industry & Financial Markets Association, Inc. (SIFMA) is an organization that represents the securities industry in the United States. The private company is based in New York, NY and has subsidiaries in the United States. The company's main focus is advocating for effective and resilient capital markets. The CEO of the company is Kenneth E. Bentsen.